#MARKSANSAsset: Marksans Pharma Ltd (MARKSANS)
Breakout Level: 258
Potential Target: 290
Stop Loss: 244
Timeframe: Short to Medium term
Risk to Reward ratio : 1:2
Rationale:
Fundamentals -
Fundamentally decent stock with the following attributes:
* ROCE - 20.1%
* ROE - 16.8%
* Debt to Equity - 0.13
* Stock
Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
8.40 INR
3.81 B INR
26.23 B INR
214.59 M
About MARKSANS PHARMA LTD
Sector
Industry
CEO
Mark Bosco Saldanha
Website
Headquarters
Mumbai
Founded
1992
ISIN
INE750C01026
FIGI
BBG000D7VQ16
Marksans Pharma Ltd. engages in the research, manufacture, marketing, and sale of pharmaceutical formulations. Its product portfolio includes tablets, hard capsules, soft gelatin capsules, oral liquids, and ointments. It operates through the following geographical segments: US and North America, Europe and UK, Australia and New Zealand, India, and Rest of World. The company was founded by Mark Bosco Saldanha on April 16, 1992 and is headquartered in Mumbai, India.
Related stocks
Marksans Pharma Date 08.03.2025
Marksans Pharma
Timeframe : Day Chart
Technical Remark :
1 There might be a lot of pain left in pharma sector as sector PE benchmark is 35 & a lot of stocks are riding over that despite of 30%-40% correction from top
2 At wave C 61% (marked in yellow) is very crucial, below that
MARKSANS Pharma – Is the Pullback Over? Watch for the Next Move!Hello everyone! I hope you’re all doing great! 😊 Today, I’ve got an exciting setup for you – MARKSANS PHARMA! After a period of consolidation, MARKSANS Pharma is showing signs of a potential breakout! The stock has been trading in a range between 251 (support) and 279 (resistance), and it looks
#LONG on MARKSANS PHARMA; Broke out Multi-year ascending channelMARKSANS was trading within an ascending channel since Nov '2005.
It broke out from the channel in the ongoing month of Nov '23 forming a large bullish candle on a monthly time frame, rising approximately 51%.
The Stock rose nearly 11.88% today hitting an All Time High of 165.
Marksans Pharma SL 1Hr candle close only, Target Trigger Price
All detail for chat. good entry at mark price only. and must stoploss minimum risk and good profit. risk ratio 1:1 to manage modified SL. This is not call, Just my idea. Please understand your risk and take full responsibility of your actions
Marksans Pharma Ltd - Breakout Setup, Move is ON...#MARKSANS trading above Resistance of 262
Next Resistance is at 344
Support is at 194
Here are previous charts:
Chart is self explanatory. Levels of breakout, possible up-moves (where stock may find resistances) and support (close below which, setup will be invalidated) are
Marksans Pharma Ltd - Breakout Setup, Move is ON...#MARKSANS trading above Resistance of 212
Next Resistance is at 262
Support is at 180
Here are previous charts:
Chart is self explanatory. Levels of breakout, possible up-moves (where stock may find resistances) and support (close below which, setup will be invalidated) are cle
See all ideas
Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
The current price of MARKSANS is 246.15 INR — it has increased by 0.19% in the past 24 hours. Watch MARKSANS PHARMA LTD. stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on BSE exchange MARKSANS PHARMA LTD. stocks are traded under the ticker MARKSANS.
MARKSANS stock has fallen by −5.77% compared to the previous week, the month change is a −2.86% fall, over the last year MARKSANS PHARMA LTD. has showed a 53.99% increase.
We've gathered analysts' opinions on MARKSANS PHARMA LTD. future price: according to them, MARKSANS price has a max estimate of 323.00 INR and a min estimate of 280.00 INR. Watch MARKSANS chart and read a more detailed MARKSANS PHARMA LTD. stock forecast: see what analysts think of MARKSANS PHARMA LTD. and suggest that you do with its stocks.
MARKSANS reached its all-time high on Dec 5, 2024 with the price of 358.50 INR, and its all-time low was 1.25 INR and was reached on May 18, 2012. View more price dynamics on MARKSANS chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
MARKSANS stock is 2.74% volatile and has beta coefficient of 1.64. Track MARKSANS PHARMA LTD. stock price on the chart and check out the list of the most volatile stocks — is MARKSANS PHARMA LTD. there?
Today MARKSANS PHARMA LTD. has the market capitalization of 108.96 B, it has decreased by −4.44% over the last week.
Yes, you can track MARKSANS PHARMA LTD. financials in yearly and quarterly reports right on TradingView.
MARKSANS PHARMA LTD. is going to release the next earnings report on Aug 8, 2025. Keep track of upcoming events with our Earnings Calendar.
MARKSANS net income for the last quarter is 905.46 M INR, while the quarter before that showed 1.05 B INR of net income which accounts for −13.41% change. Track more MARKSANS PHARMA LTD. financial stats to get the full picture.
Yes, MARKSANS dividends are paid annually. The last dividend per share was 0.60 INR. As of today, Dividend Yield (TTM)% is 0.25%. Tracking MARKSANS PHARMA LTD. dividends might help you take more informed decisions.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. MARKSANS PHARMA LTD. EBITDA is 5.29 B INR, and current EBITDA margin is 20.16%. See more stats in MARKSANS PHARMA LTD. financial statements.
Like other stocks, MARKSANS shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade MARKSANS PHARMA LTD. stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So MARKSANS PHARMA LTD. technincal analysis shows the neutral today, and its 1 week rating is buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating MARKSANS PHARMA LTD. stock shows the buy signal. See more of MARKSANS PHARMA LTD. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.